共 50 条
- [1] Safety of ustekinumab in IBD: Final pooled long-term safety analysis through 5 years in CD and 4 years in UC JOURNAL OF CROHNS & COLITIS, 2023, 17 : I55 - I55
- [3] Safety of Ustekinumab in Older IBD Patients (≥60 Years): Pooled Safety Analysis Through 5 Years in CD and 2 Years in UC and All Approved Indications AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S415 - S415
- [8] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results From the UNIFI Long-Term Extension AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S525 - S526
- [9] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance Study AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (05): : 910 - 921
- [10] Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis JOURNAL OF CROHNS & COLITIS, 2024, 18 (07): : 1091 - 1101